Metagenomi Therapeutics, Inc.

MGX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 119 employees
34
SEC Filings
$1.35
Close 2026-05-27
119
Employees

Business Summary

5 Item 1A. Risk Factors 34 Item 1B. Unresolved Staff Comments 97 Item 1C. Cybersecurity 98 Item 2. Properties 98 Item 3. Legal Proceedings 99 Item 4. Mine Safety Disclosures 99 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 100 Item 6. [Reserved] 100 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 101 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 111 Ite...

Latest Stock Quote

MGX 2026-05-27 $1.35 O:$1.33 H:$1.42 L:$1.31 Vol:0.3M VWAP:$1.3928
origin leaf: 73462e6c0e412066d951890d923fa141fbc5776416eb75adef875c0d8247d4be

Next Earnings

Q2 FY2026 — expected 2026-09-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-093976EDGAR111K words
2025-03-172024-12-310000950170-25-040217EDGAR—
2024-03-272023-12-310000950170-24-036838EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-276150EDGAR76K words
2025-08-122025-06-300000950170-25-107308EDGAR—
2025-05-132025-03-310000950170-25-070463EDGAR—
2024-11-132024-09-300000950170-24-126273EDGAR—
2024-08-142024-06-300000950170-24-096665EDGAR—
2024-05-142024-03-310000950170-24-059504EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001193125-26-093943EDGAR2K words
2026-01-120001193125-26-009928EDGAR—
2025-11-120001193125-25-276135EDGAR—
2025-10-010001193125-25-226878EDGAR—
2025-08-120000950170-25-107304EDGAR—
2025-06-110000950170-25-084529EDGAR—
2025-05-140000950170-25-070906EDGAR—
2025-05-130000950170-25-070448EDGAR—
2025-03-170000950170-25-040453EDGAR—
2025-03-170000950170-25-040238EDGAR—

34 total filings indexed. 15 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001785279
TickerMGX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
Websitehttps://metagenomi.co
Listed2024-02-09

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 0b2fb899095e9d73c03aae50eb221704142a5d3325ce4fee7a5536fc0cbffd97
parent: 4c4c8369da6ab104e4f7be2fe21a9991d7543ae87403455e88e6e1404c298aef
content hash: 21cc3bc69c159aff3582547cd951dd1d794c854bf05a7526f0f95372e444a50a
signed: 2026-06-02T19:01:52.704Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf